SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

SunTrust Robinson Humphrey Maintains Buy on Dicerna Pharmaceuticals, Raises Price Target to $33

SunTrust Robinson Humphrey maintains Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy and raises the price target from $28 to $33.

Benzinga · 05/11/2020 17:37

SunTrust Robinson Humphrey maintains Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy and raises the price target from $28 to $33.